165 related articles for article (PubMed ID: 2258577)
1. HLA-DR4 associated response to corticosteroids in Graves' ophthalmopathy patients.
van der Gaag R; Wiersinga WM; Koornneef L; Mourits MP; Prummel MF; Berghout A; de Vries RR; Schreuder GM; D'Amaro J
J Endocrinol Invest; 1990 Jun; 13(6):489-92. PubMed ID: 2258577
[TBL] [Abstract][Full Text] [Related]
2. Association of HLA antigen BW35 with severe Graves' ophthalmopathy.
Sergott RC; Felberg NT; Savino PJ; Blizzard JJ; Schatz NJ; Sanford CA
Invest Ophthalmol Vis Sci; 1983 Jan; 24(1):124-7. PubMed ID: 6600737
[TBL] [Abstract][Full Text] [Related]
3. HLA-DR associations with Graves' disease in eastern Hungary.
Stenszky V; Kozma L; Balazs C; Farid NR
Clin Invest Med; 1983; 6(3):181-4. PubMed ID: 6580983
[TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulin versus corticosteroid in treatment of Graves' ophthalmopathy.
Baschieri L; Antonelli A; Nardi S; Alberti B; Lepri A; Canapicchi R; Fallahi P
Thyroid; 1997 Aug; 7(4):579-85. PubMed ID: 9292946
[TBL] [Abstract][Full Text] [Related]
5. Genetic differences shown by HLA typing among Japanese patients with euthyroid Graves' ophthalmopathy, Graves' disease and Hashimoto's thyroiditis: genetic characteristics of euthyroid Graves' ophthalmopathy.
Inoue D; Sato K; Maeda M; Inoko H; Tsuji K; Mori T; Imura H
Clin Endocrinol (Oxf); 1991 Jan; 34(1):57-62. PubMed ID: 2004473
[TBL] [Abstract][Full Text] [Related]
6. Ciclosporine and Graves' ophthalmopathy.
Gayno JP; Strauch G
Horm Res; 1987; 26(1-4):190-7. PubMed ID: 3596468
[TBL] [Abstract][Full Text] [Related]
7. Patients with Graves' disease who developed insulin autoimmune syndrome (Hirata disease) possess HLA-Bw62/Cw4/DR4 carrying DRB1*0406.
Uchigata Y; Kuwata S; Tsushima T; Tokunaga K; Miyamoto M; Tsuchikawa K; Hirata Y; Juji T; Omori Y
J Clin Endocrinol Metab; 1993 Jul; 77(1):249-54. PubMed ID: 8325948
[TBL] [Abstract][Full Text] [Related]
8. HLA and autoimmune endocrine disease 1985.
Farid NR; Thompson C
Mol Biol Med; 1986 Feb; 3(1):85-97. PubMed ID: 3485759
[TBL] [Abstract][Full Text] [Related]
9. Correlation of HLA types and clinical findings in Japanese patients with hyperthyroid Graves' disease: evidence indicating the existence of four subpopulations.
Inoue D; Sato K; Enomoto T; Sugawa H; Maeda M; Inoko H; Tsuji K; Mori T; Imura H
Clin Endocrinol (Oxf); 1992 Jan; 36(1):75-82. PubMed ID: 1559302
[TBL] [Abstract][Full Text] [Related]
10. Genetic factors in Graves' ophthalmopathy.
Frecker M; Stenszky V; Balazs C; Kozma L; Kraszits E; Farid NR
Clin Endocrinol (Oxf); 1986 Nov; 25(5):479-85. PubMed ID: 3113776
[TBL] [Abstract][Full Text] [Related]
11. Human lymphocyte antigens (HLA) and Graves' disease in Turkey.
Orhan Y; Azezli A; Carin M; Aral F; Sencer E; Molvalilar S
J Clin Immunol; 1993 Sep; 13(5):339-43. PubMed ID: 7902362
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of immune damage in Graves' ophthalmopathy.
Hiromatsu Y; Wang PW; Wosu L; How J; Wall JR
Horm Res; 1987; 26(1-4):198-207. PubMed ID: 3596469
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of autoimmune ophthalmopathy from Graves' hyperthyroidism by analysis of genetic markers.
Kendall-Taylor P; Stephenson A; Stratton A; Papiha SS; Perros P; Roberts DF
Clin Endocrinol (Oxf); 1988 Jun; 28(6):601-10. PubMed ID: 3254259
[TBL] [Abstract][Full Text] [Related]
14. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
[TBL] [Abstract][Full Text] [Related]
15. Extraocular muscle antibodies and the occurrence of ophthalmopathy in Graves' disease.
de Bellis A; Perrino S; Coronella C; Sansone D; Ruocco G; Tirelli G; Di Martino S; Conte M; Bellastella G; Wall JR; Bellastella A; Bizzarro A
Clin Endocrinol (Oxf); 2004 Jun; 60(6):694-8. PubMed ID: 15163332
[TBL] [Abstract][Full Text] [Related]
16. Immunogenetics of Graves' ophthalmopathy.
Weetman AP; So AK; Warner CA; Foroni L; Fells P; Shine B
Clin Endocrinol (Oxf); 1988 Jun; 28(6):619-28. PubMed ID: 2908181
[TBL] [Abstract][Full Text] [Related]
17. [Soluble IL-2 receptor levels in patients with Graves' ophthalmopathy].
Yang H; Wu Z; Huang X; Xie C; Yang P
Yan Ke Xue Bao; 1999 Jun; 15(2):78-80. PubMed ID: 12579704
[TBL] [Abstract][Full Text] [Related]
18. Human leukocyte antigens associated with hyperthyroid Graves ophthalmology in Japanese patients.
Ohtsuka K; Nakamura Y
Am J Ophthalmol; 1998 Dec; 126(6):805-10. PubMed ID: 9860004
[TBL] [Abstract][Full Text] [Related]
19. Peripheral parameters of oxidative stress in patients with infiltrative Graves' ophthalmopathy treated with corticosteroids.
Bednarek J; Wysocki H; SowiĆski J
Immunol Lett; 2004 May; 93(2-3):227-32. PubMed ID: 15158621
[TBL] [Abstract][Full Text] [Related]
20. Major histocompatibility complex (MHC) factors predisposing to and protecting against Graves' eye disease.
Frecker M; Mercer G; Skanes VM; Farid NR
Autoimmunity; 1988; 1(4):307-15. PubMed ID: 2979624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]